OBJECTIVE: To determine whether the slimming effects of treatment with oleoyl-estrone (OE) in liposomes of normal and obese rats are permanent, or disappear as soon as the treatment with the drug ceased. This study was devised to gain further knowledge on the postulated role of OE as a ponderostat signal, evaluating whether (in addition) it can lower the ponderostat setting of the rat. DESIGN: The rats were infused for 14 d (using osmotic minipumps) with oleoyl-estrone in liposomes at a dose of 3.5 m mmolakg Á Á d, and were studied up to one month after the treatment ceased. SUBJECTS: Young adult lean controls (CL) or treated (TL) and obese controls (CO) or treated (TO) Zucker rats. MEASUREMENTS: Energy balance, blood glucose, liver glycogen, plasma insulin, leptin corticosterone, ACTH and estrone (free and total) concentrations, and expression of the OB gene in white adipose tissue (WAT). RESULTS: The loss of body weight caused by OE was recovered quickly in the TO, which gained weight at the same rate as the CO. TL rats, however remained at the low weight attained for one month after the treatment ceased. However, no differences were observed in calculated energy expenditure (EE) between the TL and TC rats once treatment had stopped. In TL and TO rats, liver glycogen concentrations decreased to normal shortly after treatment ceased, and leptin expression and concentrations remained normal and unchanged after the end of OE treatment. In TO rats, plasma glucose, insulin and leptin were lower than in the CO. Total estrone concentrations decreased rapidly in TL rats and more slowly in the TO, and free estrone followed a similar pattern. CONCLUSION: Continuous infusion of liposomes loaded with OE resulted in a decreased energy intake (EI), maintenance of EE and the utilization of body fat reserves in lean and obese rats alike. This process ended in obese rats as soon as the infusion ceased, so that even when the levels of free and total estrone in plasma remained high, there was a marked (and relatively fast) shift toward the basal situation, which translated into an increase in EI, maintenance of estimated EE and a marked buildup of energy stores. In lean rats, the effects of OE on leptin concentrations and OB gene expression persisted after infusion ended.
Introduction
Oleoyl-estrone (OE) administration in lipoproteinmimicking liposomes results in the steady loss of body fat in normal, 1 genetically obese 2 and cafeteria-fed 3 rats. This is the consequence of a decreased food intake and the maintenance of thermogenesis; this is supported by using internal fat stores, but sparing body protein. 4 OE induces the counter-regulatory secretion of glucocorticoids, which limit the extent of OE-induced loss of energy stores. 5, 6 Leptin, the product of the OB gene, 7 induces the loss of body fat in obaob mice, 8 by lowering food intake and maintaining energy expenditure (EE) through increased thermogenesis and activity. 9 The similarities between leptin and OE effects on fat stores, go no further, because the slimming effects of leptin require functional leptin receptors, 10 and thus it does not affect dbadb mice 11, 12 nor Zucker faafa rats, 12, 13 as both lack fully operative leptin receptors. However, the slimming effects of OE do not depend on leptin receptors, since the Zucker faafa rats are fully affected by its administration. 2 OE greatly reduces the expression of the OB gene in normal rats, leading to a lowering of circulating leptin. 6 This effect is not observed in faafa rats, which maintain the expression of the OB gene and have unaltered leptin concentrations under OE treatment. 5 This implies that leptin receptors are needed for the leptin-depressing effect of OE, and also that the effects of OE are not mediated by leptin.
Zucker obese rats are less able to dispose of injected OE, 14 and cannot maintain stable circulating levels of estrone under OE treatment, 5 unlike normal rats. 6 Here we have studied whether the effects of OE on energy balance are maintained after cessation of a two-week pharmacological treatment, paying special attention to the time needed for full hormonal normalization and the disappearance of injected OE from the blood.
Materials and methods
Twelve-week-old female adult Zucker lean (Faa?) and obese (faafa) rats from Charles River (France), weighing 198AE 3 g (lean) and 400AE 7 g (obese) were used. They were maintained under standard conditions (21 C, 60±70% relative humidity, 12 h light: 12 h dark cycle), and fed standard rat chow pellets (B&K, Sant Vicent dels Horts, Spain) ad libitum. All the animals were kept, handled and killed following the guidelines established by the European Community and the Governments of Catalonia and Spain.
Chemicals and standards from Sigma (St Louis, MO) and solvents from Merck (Darmstadt, Germany) were of reagent quality. OE was synthesized from oleoyl-chloride and estrone in an anhydrous pyridine medium. 1, 15 OE was then incorporated into liposomes;
1 the liposome suspension, containing 20% lipid and varying concentrations of OE, was used to ®ll osmotic minipumps (Alzet 2ML-2 from Alza, Palo Alto, CA), which were inserted under the skin on the back of the rat and connected via a short polyethylene capillary tube (PE-10 from Becton-Dickinson, Parsippanny, NJ) to the left jugular vein, under ethyl ether anaesthesia. The minipumps released 5 mLah for 14 d at a constant rate. The dose administered to the rats was 3.5 mmolad Á kg of body weight. In the control rats, the minipumps contained only the liposome suspension, without OE. All rats were weighed daily, as was the food they consumed. Four groups of rats were studied: 1) control-lean (CL), 2) controlobese (CO), 3) treated-lean (TL) and 4) treated-obese (TO).
Two weeks after the implanation of the pumps, they had already ceased releasing the liposome suspension. On days 14, 15, 18, 23, 30 and 42 after the implanation of the minipumps, groups of ®ve rats from each of the four groups were killed by decapitation and their blood was recovered in dry heparinized beakers. Samples of visceral white adipose tissue (WAT, periovaric fat pads) and liver were immediately dissected and frozen in liquid nitrogen. 16 Blood was centrifuged to obtain plasma, which was then frozen. All samples were kept at 7 80 C until processing.
Free estrone was measured by direct radioimmunoassay (RIA) with tritium labelled estrone (Amersham, UK) in dried ethyl ether plasma extracts, 17 using speci®c estrone antibodies (E-3135, Sigma). Plasma fatty acyl esters of estrone were measured using a previously described method. 17 Plasma samples were also used for the measurement of plasma leptin using a speci®c rat leptin RIA kit (RL-83K from Linco, St Charles, MO), of insulin, 18 using a rat insulin kit (Amersham), of corticosterone, using labelled hormone from Amersham and polyclonal antibodies from Sigma (C-8784), and of ACTH, using a speci®c kit (07-106101 from ICN, Costa Mesa, CA). Blood samples were also used to determine the concentration of glucose 19 and urea, the latter with a ready-to-use kit (B 8035 from Menarini, Milano, Italy). Liver samples were used for the extraction, puri®cation 20 and determination of glycogen content. 21 Total RNA was extracted from adipose tissue fat pad samples with the Tri-Pure isolation reagent (1667 165 from Boehringer Mannheim, Mannheim, Germany). The proportion of OB gene mRNA vs total RNA, was determined using appropriate oligonucleotides through Northern blot transfer. 22 Fixed oligonucleotides were detected by chemiluminescence, the signals being visualized on exposure to x-ray ®lm which was scanned and quanti®ed with a laser scanner (Seiko Epson 67 8500, Seiko, Nagano, Japan), using the Phoretix (Newcastle-upon-Tyne, UK) software.
The energy content of the pellet diet and in the droppings of ®ve lean and ®ve obese rats fed the pellet diet kept in metabolic cages for 6 d (only the last two were used for the analyses) were measured with an adiabatic bomb calorimeter (IKA C-7000, IKA Analysentechnik, Heitersheim, Germany). The droppings contained 15.0AE 0.9% of the gross energy ingested (15.97 kJag of pellet) in the lean and 19.9 AE 0.4% in the obese rats. After correcting for metabolisable energy content, the mean net ef®ciency of dietary energy utilization was calculated: 96.4% in the lean and 92.0% in the obese rats.
The EE for 24 h periods was estimated using the equation:
where E i stands for the net energy ingested (calculated from the amount of food consumed in the 24 h prior to weighing the rat and the net energy of the food pellets ingested, corrected for the ef®ciency of dietary energy utilization) and E e is the EE value. E s is the energy stored as change in body mass; the equivalences in energy gained and lost per gram of body weight change, were taken from previous analysis of body composition made of lean and obese 2 control and treated rats. The changes in protein and lipid content (and their energy equivalence) were related to changes in body weight. Thus we obtained the approximate energy equivalences of body weight changes: 14.1 kJag (gain) and 14.8 kJag (loss) in lean rats and Oleoyl-estrone affects ponderostat in rats C Ada Ân et al 21.8 kJag (gain) and 18.4 kJag (loss) in the obese. The changes were considered uniform for the whole period studied for the sake of calculations. These values allowed the estimation of successive 24 h EE values. All energy values have been expressed in kJad to enable direct comparison.
The data for EE thus obtained, are only an estimate of the actual values, since no precise data on the changes of body energy stores and ef®ciency of food energy assimilation were available for the animals used in the experiment. In any case, the data obtained are presented because they give a general idea of the effects induced by OE treatment.
The data on estrone disappearance from blood plasma were ®tted to a decay equation: The statistical signi®cance of differences between groups was assessed by ANOVA programs and the Student's t test.
Results Figure 1 shows the changes in body weight in lean and obese Zucker rats during and after receiving a continuous infusion of OE in liposomes or plain liposomes. The weight of both lean and obese rat controls increased steadily, with a mean gain of 18.5% (that is, 37 g) in lean and 22.6% (that is, 90 g) in the obese in six weeks, which amounts to a mean rate of 0.54 kJad (0.46% BWad) or 2.02 kJad (obese) (0.51% BWad). The weight of rats receiving OE decreased steadily, with a mean loss of 5.6% (that is, 12 g) in lean and 4.5% (that is, 18 g) in the obese in 14 d, which amounts to a mean rate of 0.50 kJad (lean) (0.40 percentage body weight (%BW)ad) or 0.97 kJad (obese) (0.25% BWad). When the infusions ceased (day 15), lean rats maintained their low weight, gaining only a mean 3.4% (that is, 7 g) in 28 d; the obese, however, recovered the weight-increase rate of controls and gained weight steadily: 15.6% (that is, 62 g) in 28 d. The mean rates of weight change were 0.14 kJad (lean) (0.12% BWad) and 2.02 kJad (obese) (0.55% BWad).
The estimated energy balance of lean rats is presented in Figure 2 . EE was fairly uniform in lean animals, increasing with age (and higher body weight); the increase was parallel to food intake, the small difference corresponding to energy storage as body components. Treatment with OE decreased the energy intake (EI) and the energy stores of the rat, which resulted in a lower decrease of EE. In the posttreatment period, food intake (and estimated EE) increased to pre-treatment levels, with only a small net storage of energy such that most of the values were not signi®cantly different from zero.
The energy balance of obese rats ( Figure 3) shows a pattern similar to that of lean rats for controls; in this case, however, the energy storage component was higher than in the lean rats. OE treatment also induced lower EI, with a net loss of body components and practically unchanged EE compared to controls. In the period following treatment, energy storage, EE and food intake, were similar to those of the controls, the patterns being indistinguishable.
The relative uniformity of the EI values, and rates of body weight change in the four groups with respect to time, allowed the relative simpli®cation of all energy data into two well differentiated periods: treatment (day 1±day 14) and post-treatment (day 15±day 42). Table 1 is a summary of the changes Figure 1 Percentage (%) body weight change in Zucker lean and obese rats during and after i.v. infusion with oleoyl-estrone in liposomes. The points represent the mean AE s.e.m. of 30 (day 1 ± day 14), 25 (day 14 ± day 15), 20 (day 16 ± day 18), 15 (day 19 ± day 23), 10 (day 24 ± day 30) or 5 (day 31 ± day 42) different animals in each group. The differences between treated and control groups were signi®cant (P`0.05, Student's t test) from day 3 onwards for lean and obese rats.
Oleoyl-estrone affects ponderostat in rats C Ada Ân et al induced in the energy budgets of lean and obese rats during these two periods, due to treatment with OE. The EI of lean and obese rats decreased during the treatment period, and energy storage changed sign. EE barely decreased with treatment in lean rats (10%) or in the obese (11%), but food intake decreased by 23% and 32%, respectively. Treatment induced a deep shift in energy partitioning (that is, deposition of internal energy stores vs EE) towards the consumption of internal stores energy. In the post-treatment period, obese rats recovered the energy storage rates of controls, but lean rats showed a lower energy storage rate than the controls and the obese. Table 2 presents the circulating glucose and urea levels, as well as the liver glycogen concentrations of lean and obese rats during the post-treatment period. The glucose concentrations in previously treated lean rats, showed no changes and were no different from those found in the controls. In the TO rats, however, glucose increased up to the control values after the OE treatment ceased. No changes were observed in circulating urea levels in any of the four groups studied. In lean and obese rats, liver glycogen decreased rapidly to normal concentrations after treatment ceased. Table 2 also shows the changes in expression of the OB gene in Zucker lean and faafa rats during the posttreatment period. In lean rats, the almost non-existent expression observed at the end of treatment, slowly but progressively recovered to almost normal concentrations, with the cessation of treatment. In the obese rats, no changes were observed during the period studied; obese rats maintained much higher expression values than those of lean rats. Table 3 presents the circulating concentrations of hormones in lean and obese rats during the posttreatment period. Lean rats showed no signi®cant changes in insulin concentrations during this period. Obese rats had much higher insulin concentrations than the lean; during the post-treatment period, insulin Oleoyl-estrone affects ponderostat in rats C Ada Ân et al concentrations were lower than controls. On the last day of treatment (day 14), lower leptin concentrations were found in lean rats than in the untreated control group; after a minimum on day 18, however, leptin concentrations in treated lean rats were indistinguishable from the controls. There were no changes in the obese rats either, but their values were much higher than those of lean rats throughout.
Plasma corticosterone did not change during the post-treatment period in lean rats, except for a low value just when treatment ceased. ACTH values did not change signi®cantly, except for a decrease at the The data are the mean of 5 ± 30 rats depending on the period measured. Statistical signi®cance of the differences between groups (P`0.05, Student's t test): * controls vs oleoyl-estrone; # lean vs obese; { treatment vs post-treatment. The data are the mean AE s.e.m of ®ve animals per group. Statistical signi®cance of the differences (ANOVA). Glucose: effect of obesity (P 0.013), oleoyl-estrone (OE) in liposomes treatment (P 0.644 lean; P`0.001 obese) and time (P 0.083 lean; P 0.001 obese). Urea: effect of obesity (P`0.001), OE treatment (P 0.027 lean; P 0.194 obese) and time (P 0.175 lean; 0.059 obese). Glycogen: effect of obesity (P 0.482), OE treatment (P 0.462 lean; P 0.424 obese) and time (P`0.001 lean; P 0.035 obese). Expression of the OB gene: effect of obesity (P`0.001), OE treatment (P`0.001 lean; P 0.381 obese) and time (P 0.013 lean; P 0.291 obese). * Differences vs controls (Student's t test, P`0.05): # differences between corresponding lean and obese groups (Student's t test, P`0.05). a The data in this column are the means of all control groups from day 14 to day 42 (that is n 30), grouped this way because there were no signi®cant differences between any of the days. The ANOVA analyses, however, were carried out using individual groups of ®ve rats per day. The data are the mean AE s.e.m. of ®ve animals per group. Statistical signi®cance of the differences (ANOVA). Insulin: effect of obesity (P`0.001), OE treatment (P 0.949 lean; P`0.001 obese) and time (P 0.709 lean; P 0.750 obese). Leptin: effect of obesity (P`0.001), OE treatment (P 0.016 lean; P 0.748 obese) and time (P 0.014 lean; P 0.144 obese). Corticosterone: effect of obesity (P 0.944), OE treatment (P 0.052 lean; P 0.084 obese)) and time (P 0,.027 lean; P 0.136 obese). ACTH: effect of obesity (P 0.009), OE treatment (P 0.002 obese) and time (P 0.037 lean; P 0.549 obese). * Differences vs controls (Student's t test, P`0.05): # differences between corresponding lean and obese groups (Student's t test, P`0.05). a The data in this column are the means of all control groups from day 14 ± day 42 (that is, n 30), grouped this way because there were no signi®cant differences between any of the day-groups. The ANOVA analyses, however, were carried out using individual groups of ®ve rats per day.
Oleoyl-estrone affects ponderostat in rats C Ada Ân et al end of the period studied. In the obese rats, however, corticosterone concentrations were already high on day 14, and climbed further, to a peak on day 18, decreasing later to the control values. ACTH levels in the obese, roughly followed this same pattern, but increased again by day 42. Figure 4 depicts the levels of free estrone and total (that is, free esteri®ed) estrone in the plasma of lean and obese rats. The concentrations of total estrone in untreated obese rats were higher (but not signi®cant) than those of the lean rats. Free estrone concentrations were also higher (P`0.05) in CO than in CL rats. The end of treatment (day 14) coincided with very high estrone concentrations (both free and total). The disappearance rate of total estrone, closely followed a decay curve, with t1 2 values for lean rats of 62 h and 160 h for the obese; that is, lean rats attained the control concentrations in about 10 d, but obese rats had not reached the control concentrations 28 d after treatment ceased. Plasma free estrone concentrations did not follow a decay curve; in any case, the clearance of free estrone was again faster in the lean than in the obese rats. Lean rats reached the control values at the end of the period studied, at which point the obese rats had not recovered the basal concentrations.
Discussion
The continuous infusion of liposomes loaded with OE into lean and obese rats, results in the modi®cation of their energy balance towards decreased EI, maintenance of EE and the utilization of body fat reserves. 1, 2, 4 This process ended for the obese rats as soon as infusion stopped. Thus, even when the concentrations of OE and estrone in the plasma were very high, there was a marked (and relatively fast) shift towards the basal situation: increased EI, maintenance of EE and a large buildup of energy stores. On the other hand, in lean rats, the effects of OE continued for a relatively long time after infusion ended, that is, the OB gene expression slowly recovered. Paradoxically, lean rats dispose of their free and esteri®ed estrone much faster than the obese, 5, 23 but the modi®cation of energy partitioning seems to have been de®nitively modi®ed by OE treatment.
The stunted increase in body mass of lean rats, long after treatment with OE ceased, may represent a modi®cation of the ponderostat setting, since the amount of energy available was maintained thanks to unchanged food intake, although EE was increased slightly. The lack of energy accumulation was accomplished with no change in glucose or urea, and the maintenance of liver glycogen stores. The metabolic situation was very similar in Zucker faafa rats, again with unchanged glycogen and urea (but with lower glucose) than the controls. But in the obese rats, a signi®cant difference occurred: they returned to the same body energy accrual rates as the controls, as soon as the OE treatment ended. However, in their post-treatment recovery, they did not approach the weight of controls but grew in a parallel course, so that OE infusion seems to have acted just as a slimming parenthesis in an otherwise unchanged fattening spree. The change induced in the ponderostat of obese rats was different from that observed in the lean rats.
The inability of obese rats to maintain the ponderostat setting, as the lean ones did, does not mean they do not respond to OE treatment, since these rats lose weight because of unbalanced EI and EE, exactly as Figure 4 Plasma free and total estrone in rats subjected to treatment with oleoyl-estrone (OE) during the post-treatment period. Open symbols: lean rats, solid black symbols: obese rats. The data are the mean AE s.e.m. of ®ve different animals. The means of all control groups from day 14 ± day 42 (that is, n 30) are given as a single point over the 15 d mark for comparison. The control data were grouped this way because there were no signi®cant differences between any of the control groups; the ANOVA analyses, however, were carried out using the individual groups. Statistical signi®cance of the differences (ANOVA): free estrone, effect of obesity (P 0.466), OE treatment (P`0.001 lean; P`0.001 obese) and time (P 0.004 lean; P`0.001 obese). Total estrone, effect of obesity (P`0.001), OE treatment (P`0.001 lean; P`0.001 obese) and time (P`0.001 lean; P 0.017 obese). The differences between lean and obese controls were signi®cant (P`0.05, Student's t test) for free but not for total estrone.
Oleoyl-estrone affects ponderostat in rats C Ada Ân et al occurs in lean rats. The main difference between lean and genetically obese Zucker rats, is the lack of functional leptin receptors in the latter. 12, 13 OE depresses the synthesis of leptin in normal rats. 6 In lean rats, however, this inhibition was largely maintained during the post-treatment period, and may be due, in part, to the high circulating concentrations of OE observed during most of the period studied. Leptin levels, were low after treatment ceased, but were nevertheless higher than expected from the low expression of the OB gene. Perhaps some compensatory change in leptin turnover allowed for the maintenance of its levels. The lack of changes in leptin and the overexpression of the OB gene observed in faafa rats post-treatment, is consistent with the lack of effects observed on the expression of this gene during treatment with OE. 5 OE elicits an increase in glucocorticoid concentrations; 5, 6 this effect continued in the post-treatment period: in the lean rats, the transient low corticosterone concentrations rapidly fade, but in the obese, the end of the treatment coincided with high ACTH and corticosterone concentrations. 5 This trend continued further after the OE infusion ended, up to day 18. The increase in corticosterone concentrations in obese rats, contrasts with the maintenance of leptin concentrations, since glucocorticoids activate the synthesis of leptin. 24 Insulin concentrations did not change in lean rats, but in the obese they were lower than their controls (albeit distinctly higher than those of lean rats) and in parallel with low glucose for most of the period studied. This contrasted with the rapid recovery of normal liver glycogen concentrations after they increased under OE treatment. 5, 6 The concurrence of normal glycogen, low glucose and low insulin is dif®cult to match with an active synthesis of fat, such as that observed in the obese rats post-treatment, and may be a consequence of lowered insulin resistance. 6 There was another marked difference between lean and obese rats during the post-treatment period: the different rates of OE disposal. The slow removal of OE from the bloodstream by obese rats, contrasts with the fast recovery of fat deposition just when the infusion ended. The change in trend for energy storage, was concurrent with high circulating OE concentrations, which were higher than those eliciting an initial slimming response. 5 This`resistance' to OE may be attributed to the counter-regulatory secretion of glucocorticoids, 5 a response that is also observed in lean rats. 6 
Conclusion
From the results obtained, it can be speculated that a fully functional leptin pathway is needed for an adequate metabolism of OE andaor estrone. It may be deduced that OE control of leptin secretion also needs fully functional leptin signalling. OE affects leptin expression, but can, nevertheless, induce the loss of fat, even when leptin receptors are not functional, thus its effects are not channeled through leptin.
The main ®nding of this study is, however, that in the presence of a functional leptinergic system, OE treatment modi®es more deeply the distribution of the rat's available energy between expenditure and storage, changing the ponderostat setting. OE and leptin are closely linked in the control of body weight, and their interaction may help modify the ponderostat setting.
